neobookRx
GuidelinesOther guideline

Infusion: N-Acetylcysteine

N-ACETYLCYSTEINE INFUSION / PARVOLEX

Trade names:
Presentation and strength:

Parvolex

200mg/ml in 10ml ampoules (2g)
Cautions: see SAMF.
Anaphylaxis risk & histamine release. If only mild reaction reduce infusion rate. Stop if severe reaction
Commence N-Acetylcysteine (NAC) when acute paracetamol ingestion exceeds 10g or > 200mg/kg (whichever is less) in adults and > 200mg/kg in children
Commence NAC plasma concentration is above treatment line on Rumack-Matthew Nomogram (attached).
Paracetamol plasma concentration should be obtained 4 hours after ingestion or soonest thereafter.
Use high risk treatment line for patients with liver impairment, alcohol abusers and patients taking enzyme inducing medication

Loading dose:
Adult:
150 mg/kg in 200ml 5% Dex over 1 hour then
50 mg/kg in 500ml 5%Dex over 4 hours then
100mg/kg in 1000ml 5% Dex over 16 hours

Paediatric:
As for adult.

Commonly for 70kg adult: 
10.5g (52.5ml) NAC in 200 ml 5% Dex
3.5g (17.5ml) NAC in 500 ml 5% Dex
7g (35ml) NAC in 1000ml 5% Dex

Neonatal:
As for paediatric.

Constant infusion:
In patients developing hepatic injury continue NAC until LFT’s normalised:
150mg/kg in 1 litre 5%Dex over 24 hours. Rate 42 ml/hr

Paediatric dosage range: 
As for adult.

Neonatal dosage range:
As for paediatric. 

Regime for 70kg adult:
Regime for paediatrics:
Mixture:
10.5g (52.5ml) NAC in 200 ml 5% Dex
3.5g (17.5ml) NAC in 500 ml 5% Dex
7g (35ml) NAC in 1000ml 5% Dex

Mixture:
Per weight – calculate to above regime

Rate:
Run at 200ml/hr for 1 hour
Run at 125ml/hr for 4 hours then
Run at 62.5ml/hr for 16 hours  

Rate:
In children adapt volume of IV fluid to age and weight appropriate volume

Alternative adult regime:
Alternative paediatric regime:
Mixture:
Mixture:
Rate:
Rate:
Additional notes:
Monitor Serum potassium


RUMACK-MATTHEW NOMOGRAM




*The nomogram is only for use with single acute ingestion

Nomogram reproduced from the Guidelines for the management of Acute Paracetamol Overdose produced by the Medicines Information Centre, UCT

Drugs mentioned

NeoHealth® ID 18794 · updated 9/15/2021